BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 19170044)

  • 1. Lymph node assessment and lymphadenectomy in prostate cancer.
    Ordon M; Nam RK
    J Surg Oncol; 2009 Mar; 99(4):215-24. PubMed ID: 19170044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
    Heidenreich A; Pfister D; Thüer D; Brehmer B
    BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
    Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
    BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
    Wagner M; Sokoloff M; Daneshmand S
    J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer.
    Joslyn SA; Konety BR
    Urology; 2006 Jul; 68(1):121-5. PubMed ID: 16806432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pelvic lymphadenectomy in prostate cancer management.
    Sivalingam S; Oxley J; Probert JL; Stolzenburg JU; Schwaibold H
    Urology; 2007 Feb; 69(2):203-9. PubMed ID: 17320652
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
    Middleton RG
    NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging lymphadenectomy should not be an antecedent to treatment in localized prostatic carcinoma.
    Paulson DF
    Urology; 1985 Feb; 25(2 Suppl):7-14. PubMed ID: 3969766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic node dissection in prostate cancer: extended, limited, or not at all?
    Hyndman ME; Mullins JK; Pavlovich CP
    Curr Opin Urol; 2010 May; 20(3):211-7. PubMed ID: 20224412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 13. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node assessment in cervical cancer: prognostic and therapeutic implications.
    Gien LT; Covens A
    J Surg Oncol; 2009 Mar; 99(4):242-7. PubMed ID: 19048600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting pelvic lymph node involvement in patients with localized prostate cancer.
    Ekman P
    Eur Urol; 1997; 32 Suppl 3():60-4. PubMed ID: 9267787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 19. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.
    Boormans JL; Wildhagen MF; Bangma CH; Verhagen PC; van Leenders GJ
    BJU Int; 2008 Dec; 102(11):1589-93. PubMed ID: 18710447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
    Briganti A; Chun FK; Salonia A; Gallina A; Zanni G; Scattoni V; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
    Urology; 2007 Jan; 69(1):147-51. PubMed ID: 17270638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.